French guidelines on <scp>TIPS</scp>: Indications and modalities
Hélène Larrue, Manon Allaire, Delphine Weil, Sandrine Barge, Dominique Thabut, Audrey Payancé, Lucile Moga, Caroline Jézequel, Florent Artru, Isabelle Archambeaud, Laure Elkrief, Frédéric Oberti, Charles Roux, Wim Laleman, Marika Rudler, Sébastien Dharancy, Nolwenn Laborde, Anne Minello, Thomas Mouillot, Elvire Desjonquères, Line Caroll Ntandja Wandji, Marc Bourlière, Nathalie Ganne‐Carrié, Christophe Bureau, for the Groupe collaboratif AFEF
Abstract
Transjugular intrahepatic portosystemic shunt (TIPS) has become essential in the treatment or prevention of portal hypertension-related complications. In the early 1990s, the primary indication was refractory bleeding. It is now proposed for the treatment of ascites for the prevention of bleeding and in patients with vascular diseases of the liver. Thus, there are a growing number of patients being treated with TIPS all over the world. The broadening of indications, the involvement of multiple stakeholders, the need for an accurate selection, the positioning in relation to transplantation and the lack of standardization in pre-therapeutic assessment, in the procedure itself and in the follow-up have led the board of the French Association for the Study of the Liver to establish recommendations.